Clinical Trial Update: Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update reports safety and efficacy results for Viacor's Percutaneous Transvenous Mitral Annuloplasty Device intended to reduce mitral regurgitat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Mitral Regurgitation

Drugs mentioned

• Percutaneous Transvenous Mitral Annuloplasty Device

Snippet

Sponsor: Viacor | Conditions: Heart Failure, Mitral Regurgitation | Phase 1, Phase 2 | Status: COMPLETED